Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$28,757
in 6 filings

Net +$49,971,226. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-21 NELSEN ROBERT Director Conversion · Series C Convertible Preferred Stock −435,142 0
2021-06-21 Klausner Richard Executive Chairman Conversion +3,765,842 3,765,842
2021-06-21 Klausner Richard Executive Chairman Conversion · Series A Convertible Preferred Stock −3,765,842 0
2021-06-21 Bishop Hans Edgar Director Conversion +546,806 3,546,806
2021-06-21 Bishop Hans Edgar Director Conversion · Series A Convertible Preferred Stock −546,806 0
2021-06-21 FRIEDMAN CATHY Director Conversion +3,765,842 3,765,842
2021-06-21 FRIEDMAN CATHY Director Purchase +17,648 $17.00 $300K 17,648
2021-06-21 FRIEDMAN CATHY Director Conversion · Series A Convertible Preferred Stock −3,765,842 0
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion +18,206,358 18,206,358
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion +18,206,358 18,206,358
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A Convertible Preferred Stock −17,771,216 0
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion · Series A Convertible Preferred Stock −17,771,216 0
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion · series C Convertible Preferred Stock −435,142 0
2021-06-21 ARCH Venture Partners IX, LLC 10% owner Conversion · Series C Convertible Preferred Stock −435,142 0

Page 11 of 11 · 214 trades